The estimated Net Worth of Thomas C Zielinski is at least $27 Million dollars as of 3 November 2020. Mr. Zielinski owns over 9,175 units of Anthem Inc stock worth over $8,643,008 and over the last 10 years he sold ANTM stock worth over $14,357,387. In addition, he makes $3,977,640 as Executive Vice President und General Counsel at Anthem Inc.
Sign up
Mr. Zielinski ANTM stock SEC Form 4 insiders trading
Thomas has made over 11 trades of the Anthem Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently he sold 9,175 units of ANTM stock worth $2,680,935 on 3 November 2020.
The largest trade he's ever made was exercising 22,936 units of Anthem Inc stock on 1 March 2017 worth over $3,074,800. On average, Thomas trades about 6,256 units every 77 days since 2015. As of 3 November 2020 he still owns at least 17,910 units of Anthem Inc stock.
You can see the complete history of Mr. Zielinski stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Thomas Zielinski biography
Thomas C. Zielinski is an a Executive Vice President, General Counsel of Anthem, Inc. Prior to joining us, Mr. Zielinski was a partner in the law firm of Morgan Lewis & Bockius, LLP since 2013. He served as Executive Vice President and General Counsel of Coventry Health Care, Inc. (“Coventry”) (health insurance) from 2007 to 2013 and as Senior Vice President and General Counsel from 2001 to 2007. Prior to joining Coventry, Mr. Zielinski spent 19 years at the law firm of Cozen & O’Connor, P.C.
What is the salary of Thomas Zielinski?
As the Executive Vice President und General Counsel of Anthem Inc, the total compensation of Thomas Zielinski at Anthem Inc is $3,977,640. There are 6 executives at Anthem Inc getting paid more, with Gail Boudreaux having the highest compensation of $15,473,100.
How old is Thomas Zielinski?
Thomas Zielinski is 69, he's been the Executive Vice President und General Counsel of Anthem Inc since 2014. There are 2 older and 22 younger executives at Anthem Inc. The oldest executive at Anthem Inc is Julie Hill, 73, who is the Independent Director.
Insiders trading at Anthem Inc
Over the last 10 years, insiders at Anthem Inc have traded over $153,319,533 worth of Anthem Inc stock and bought 10,600 units worth $3,007,039 . The most active insiders traders include Antonio F Neri, Ryan M. Schneider und Lewis Iii Hay. On average, Anthem Inc executives and independent directors trade stock every 21 days with the average trade being worth of $5,250,953. The most recent stock trade was executed by Charles Morgan Jr Kendrick on 9 June 2022, trading 6,328 units of ANTM stock currently worth $1,806,771.
What does Anthem Inc do?
Anthem is a leading health benefits company dedicated to improving lives and communities, and making healthcare simpler. Through its affiliated companies, Anthem serves more than 110 million people, including approximately 43 million within its family of health plans. We aim to be the most innovative, valuable and inclusive partner.
What does Anthem Inc's logo look like?
Complete history of Mr. Zielinski stock trades at Anthem Inc
Anthem Inc executives and stock owners
Anthem Inc executives and other stock owners filed with the SEC include:
-
Gail Boudreaux,
President, Chief Executive Officer, Director -
Felicia Norwood,
Executive Vice President, President - Government Business Division -
Gloria McCarthy,
Executive Vice President, Chief Administrative Officer -
Gail Koziara Boudreaux,
Pres, CEO & Director -
John Gallina,
Chief Financial Officer, Executive Vice President -
Peter Haytaian,
Executive Vice President, President of Commercial and Specialty Business Division -
Thomas Zielinski,
Executive Vice President, General Counsel -
John Edward Gallina,
Exec. VP & CFO -
Gloria Marie McCarthy,
Exec. VP and Chief Admin. Officer -
Peter David Haytaian Esq.,
Exec. VP and Pres of Diversified Bus. & IngenioRx -
Felicia Farr Norwood,
Exec. VP & Pres of Gov. Bus. Division -
Elizabeth Tallett,
Independent Chairman of the Board -
Ramiro Peru,
Independent Director -
Julie Hill,
Independent Director -
Robert Dixon,
Independent Director -
Lewis Hay,
Independent Director -
R. Kerry Clark,
Independent Director -
Antonio Neri,
Independent Director -
Bahija Jallal,
Independent Director -
Ryan Schneider,
Independent Director -
Chris Rigg,
Vice President Investor Relations -
Ronald Penczek,
Senior Vice President, Chief Accounting Officer, Controller -
Prakash Patel,
Executive Vice President, President - Diversified Business Group -
Leah Stark,
Chief Human Resource Officer, Executive Vice President -
Stephen Vartan Tanal C.F.A.,
VP of Investor Relations -
Thomas H. Miller,
Sr. VP & Chief Information Officer -
Anil Bhatt,
Chief Technology Officer -
Ronald William Penczek,
Sr. VP, Controller & Chief Accounting Officer -
Scott Wayne Anglin,
SVP, Treasurer & Chief Investment Officer -
Joseph Swedish,
President & CEO -
William J Ryan,
Director -
George A Jr Schaefer,
Director -
Jose D. Tomas,
EVP & Chief HR Officer -
Jacquelyn H Wolf,
EVP & Chief HR Officer -
Craig E Samitt,
EVP & Chief Clinical Officer -
Wayne S De Veydt,
EVP & Chief Financial Officer -
Brian T Griffin,
EVP & President, CSBD -
Samuel R Md Nussbaum,
EVP & Chief Medical Officer -
Martin B Silverstein,
EVP & Chief Strategy Officer -
Kenneth R Goulet,
EVP, Commercial & Specialty -
Blair Williams Todt,
EVP and Chief Legal Officer -
Jeffrey D. Alter,
EVP, IngenioRx & Anthem Health -
Susan D. De Vore,
Director -
Charles Morgan Jr Kendrick,
EVP & President, Commercial